Evaluating Extracorporeal Renal Replacement Therapies: Balancing Budgetary Considerations with Ethical Implications
Sign Up to like & getrecommendations! Published in 2025 at "Blood Purification"
DOI: 10.1159/000545389
Abstract: Abstract Background: Evaluating extracorporeal therapies for end-stage kidney disease (ESKD) requires balancing cost-effectiveness with patient-centered care. With dialysis costs exceeding EUR 2 billion annually in Italy and USD 29 billion in the USA, assessing the… read more here.
Keywords: extracorporeal renal; replacement therapies; therapies balancing; ethical considerations ... See more keywords